The World Health Organization (WHO) expresses deep concern about the implications of the immediate funding pause for HIV programmes in...
HIV
Africa must take ownership of its HIV response, write Izukanji Sikazwe and Magda Robalo, co-chairs of the African-led HIV Control...
Lenacapavir (LEN), a groundbreaking HIV-1 capsid inhibitor developed by Gilead Sciences, stands on the brink of revolutionizing HIV prevention. As...
HIV medicine dolutegravir has a significantly smaller carbon footprint than similar antiretroviral medication. The lifesaving HIV treatment dolutegravir (DTG), used...
Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million...
